KPWHRI in the Media
News media often cover Kaiser Permanente Washington research.
Here are selected mentions.
2026
MARCH
Blood test predicts dementia risk in women years before symptoms begin
Read related KPWHRI story.
New research by Linda McEvoy, PhD, and collaborators found that a blood-based biomarker called p-tau217 is strongly linked to future dementia risk in women. Further studies are needed to determine how p-tau217 testing might be used in routine clinical care.
- Drug Discovery News, Mar. 16
Blood test may predict Alzheimer’s risk up to 25 years before symptoms - HealthDay, Mar. 13
p-tau217 linked to incident MCI, dementia 25 years later in older women - HealthDay TV, Mar. 13
Simple blood test may predict dementia in women up to 25 years before symptoms - Healio, Mar. 13
Blood-based biomarker linked to future dementia, mild cognitive impairment risk in women - HuffPost, Mar. 13
This test may predict dementia risk in women up to 25 years in advance, study suggests - Science Alert, Mar. 13
Simple blood test can predict dementia risk in women decades before symptoms appear - KPBS Public Media, Mar. 13
USCD study: Simple blood test may predict dementia decades early - Medical News Today, Mar. 12
Blood test may predict dementia up to 25 years before symptom onset in women - Alzheimer’s Society UK, Mar. 11
New study suggests blood test could predict dementia risk in women - NBC San Diego, Mar. 10
UC San Diego scientists find biomarker signaling dementia in women 25 years early - Fox News, Mar. 10
Lurking dementia risk exposed by breakthrough test 25 years before symptoms - KTLA, Mar. 10
New blood test predicts dementia in women
Participant in historic COVID-19 vaccine trial looks back after 6 years
Read related KPWHRI story.
Neal Browning, one of the first people to ever receive a COVID-19 shot, reflected on his participation in KPWHRI’s ground-breaking trial of the Moderna vaccine in March 2020. "Looking back, I would do it all over again, and, if anything, would use my voice and limited reach to push harder for vaccine literacy and advocacy," Browning said.
- Newsweek, Mar. 18
First man in the US to get COVID jab reveals side effects 6 years later
Using patient preferences to guide antidepressant selection
Read editorial.
An editorial in JAMA by Greg Simon, MD, MPH, was quoted in a story looking at new research on a web-based decision-support tool that personalizes antidepressant selection. Simon praised the tool’s real-time usability and the study’s approach to tailored antidepressant selection.
- Medscape, Mar. 11
Novel tool helps guide antidepressant selection
FEBRUARY
Well-timed outreach boosts awareness of repeat screening for lung cancer, study finds
Read related KPWHRI story.
Karen Wernli, PhD, joined the CHEST Podcast to share her research on a communications intervention to encourage repeat lung cancer screening.
- CHEST Podcast, Feb. 2
Effectiveness of health communication intervention to improve knowledge on timeliness to return for annual lung cancer screening: The Larch Trial
JANUARY
Improving cannabis use screening and care
Research led by Tessa Matson, PhD, MPH, underscored the value of integrating cannabis screening into primary care to help identify patients with cannabis use disorder and initiate treatment.
- AHRQ News Now, Jan. 6
Intervention integrates cannabis use disorder screening into primary care - Medscape, Sept. 25
Primary care strategies aid cannabis use screening and care
Some links may require a subscription to view the content. Please check the terms and conditions on these websites and follow their rules to avoid violating copyright law when visiting them. We can’t provide you with copies of articles.
For the media
Are you a member of the news media?
Our goal is to make your job easier. We can quickly arrange for you to interview our scientists about their research or the work of others. We can also provide news releases, photographs, videos, and backgrounders—and access to patients who participate in our research and would like to be interviewed.
Media contact
For more on Kaiser Permanente Washington Health Research Institute news, please contact:
Bianca DiJulio
bianca.s.dijulio@kp.org
206-660-8333
After-hours media line: 206-448-4056
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.